InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Paul T Quinlan, a General Counsel, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 10 open-market SEC Form 4 transactions: 0 purchases worth $0 and 10 sales worth $1.0M, reported from May 15, 23 to Mar 16, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 26 | ORKAOruka Therapeutics, Inc. | SELL | 733 | $41.30 | $30K |
| Jan 16, 24 | CBAYCymaBay Therapeutics, Inc. | SELL | 5.0K | $23.58 | $118K |
| Dec 15, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 5.0K | $21.98 | $110K |
| Nov 15, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 5.0K | $17.38 | $87K |
| Oct 16, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 5.0K | $13.76 | $69K |
| Sep 15, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 24.0K | $16.87 | $405K |
| Aug 15, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 5.0K | $11.91 | $60K |
| Jul 14, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 5.0K | $11.81 | $59K |
| Jun 30, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 5.0K | $10.05 | $50K |
| May 15, 23 | CBAYCymaBay Therapeutics, Inc. | SELL | 5.0K | $10.37 | $52K |